These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4980077)

  • 1. [Isoniazid effect despite isoniazid resistance? An experimental study].
    Freerksen E; Rosenfeld M; Matsumiya T
    Prax Pneumol; 1969 Jul; 23(7):450-64. PubMed ID: 4980077
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of antitubercular agents of the 2d series: ethionamide, ethoxyd cycloserine and pyrazinamide on the development of drug resistance of Mycobacterium tuberculosis to tubazide and phthivazide].
    Makeeva OO
    Farmakol Toksikol; 1969; 32(2):202-5. PubMed ID: 4977183
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of DNA-tropic substances used jointly with tuberculostatic preparations on the development of drug resistance in Mycobacterium tuberculosis].
    Il'ina TB; Vishnevskiĭ BI
    Probl Tuberk; 1980 May; (5):67-70. PubMed ID: 6770368
    [No Abstract]   [Full Text] [Related]  

  • 4. [Secondary resistance of tubercle bacilli to antibiotics].
    Kurdziel Z
    Przegl Lek; 1966; 22(10):645-8. PubMed ID: 4960191
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies of the polychemoresistance of Mycobacterium tuberculosis].
    Curci G; De Franciscis V; Giuliano V
    Arch Monaldi; 1970; 25(2):99-114. PubMed ID: 4994908
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interaction of antitubercular agents. I. Combined action of rifampicin, isonicotinic acid hydrazide, streptomycin and para-aminosalicylic acid on the growth of strains of tubercle bacilli].
    Janowiec M; Zwolska-Kwiek Z; Wiśniewska A; Wróblewska H
    Pneumonol Pol; 1977 Jun; 45(6):425-30. PubMed ID: 406600
    [No Abstract]   [Full Text] [Related]  

  • 7. The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid.
    Steinbrück PW
    Acta Tuberc Pneumol Belg; 1969; 60(3):413-6. PubMed ID: 4984421
    [No Abstract]   [Full Text] [Related]  

  • 8. [The tuberculostatic test].
    Rudoĭ NM
    Lab Delo; 1966; 7():427-31. PubMed ID: 4170791
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug resistance of Mycobacterium tuberculosis].
    Malaguzzi Valeri F; Rossi F
    G Pneumol; 1970 Apr; 14(2):121-5. PubMed ID: 5005066
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antitubercular effect of capreomycin in vitro].
    Janowiec M
    Gruzlica; 1969 Jul; 37(7):629-35. PubMed ID: 4981783
    [No Abstract]   [Full Text] [Related]  

  • 11. Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.
    Remis RS; Jamieson F; Chedore P; Haddad A; Vernich L
    Clin Infect Dis; 2000 Aug; 31(2):427-32. PubMed ID: 10987700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary and secondary resistance of Mycobacterium tuberculosis to the primary antitubercular agents in the demonstration area of the SFRJ].
    Perak M
    Tuberkuloza; 1967; 19(5):505-11. PubMed ID: 4971781
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug resistance of Mycobacterium tuberculosis in Chandigarh.
    Mahajan RC; Agarwal SC
    Indian J Med Res; 1968 Aug; 56(8):1180-7. PubMed ID: 4179833
    [No Abstract]   [Full Text] [Related]  

  • 14. Trends in drug resistance of mycobacterium tuberculosis.
    Hejny J
    Indian J Chest Dis Allied Sci; 1982; 24(2-3):190-4. PubMed ID: 6819998
    [No Abstract]   [Full Text] [Related]  

  • 15. [Resistance to antitubercular drugs in Chile].
    Valenzuela MT; Scheel G; Ponce J; Lepe R; Velasco M; Valenzuela P
    Rev Med Chil; 1984 Jan; 112(1):76-80. PubMed ID: 6429808
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycobacterium tuberculosis drug resistance: a call to action.
    Sudre P; Cohn DL
    Int J Tuberc Lung Dis; 1998 Aug; 2(8):609-11. PubMed ID: 9712272
    [No Abstract]   [Full Text] [Related]  

  • 17. A quantitative method of determination of mycobacterium tuberculosis resistance to classical antituberculous drugs.
    Zduńczyk-Pawelek H; Kostrzewska K; Blitek-Golc D
    Pol Med J; 1966; 5(4):900-6. PubMed ID: 4960780
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug resistance and speed of growth of M. tuberculosis. 2. Vulnerable and invulnerable types of resistance.
    Zykov MP; Donets JI; Poti SJ
    Jpn J Tuberc Chest Dis; 1971 Jul; 17(1):40-56. PubMed ID: 4113512
    [No Abstract]   [Full Text] [Related]  

  • 19. [The clinical importance of the primary drug resistance of Mycobacterium tuberculosis in destructive forms of pulmonary tuberculosis].
    Khomenko AG; Chesak OI; Biazov TA; Chaikina TN
    Probl Tuberk; 1972; 50(10):28-32. PubMed ID: 4633557
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mycobacterial resistance in Lower Franconia].
    Seeliger HP; Weicksel P; Ahiaku-Brew C
    Prax Pneumol; 1970 Mar; 24(3):180-8. PubMed ID: 4985391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.